Multi-modal Explainable AI framework enhances clinician trust and diagnostic accuracy in critical healthcare settings.
The deployment of artificial intelligence in critical healthcare settings demands not only high predictive accuracy but also transparent, interpretabledecision-support mechanisms that clinicians can audit, trust, and act upon. Existing black-box deep learning models, despite strong performance onclinical benchmarks, lack the explanatory transparency required for regulatory compliance and clinical adoption. This study proposes a multi-modalExplainable AI (XAI) framework — termed ClinXAI — that integrates gradient-weighted class activation mapping (Grad-CAM), SHapley AdditiveexPlanations (SHAP), and Local Interpretable Model-agnostic Explanations (LIME) within a unified clinical decision pipeline. ClinXAI was validatedacross three critical healthcare domains: sepsis onset prediction (MIMIC-III ICU dataset, n = 52,847), diabetic retinopathy grading (EyePACS fundusimage dataset, n = 88,702), and early-stage lung cancer detection (NLST CT scan dataset, n = 26,314). The framework achieved AUC-ROC scoresof 0.943, 0.961, and 0.938 respectively, while clinician trust surveys (n = 84 specialists) rated explanation adequacy at 4.31 out of 5.0 — a 41.2%improvement over standard model outputs without explanations. Temporal feature attribution identified creatinine and lactate trajectories as the mostinfluential sepsis predictors, consistent with established clinical guidelines. ClinXAI provides a scalable, domain-agnostic architecture for transparentAI-assisted diagnosis in high-stakes healthcare environments.
No takes yet. Share an insight, caveat, or question.
Marco A. Ferretti (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: